Medical device reports from between Oct. 15, 2018, and March 31, 2019, included three reports of death, 45 reports of patient infection and 159 reports of device contamination tied to inadequate reprocessing of duodenoscopes used in procedures involving the pancreas and bile duct, according to an article on the MedTech Dive website.
The Food and Drug Administration (FDA) also released interim results from post-market studies by device makers showing contamination rates in the scopes significantly higher than preliminary findings released in December.
A total of 5.4% of all samples tested positive for “high concern” bacteria, versus 3% reported previously.
Manufacturers Olympus, Fujifilm and Pentax have not complied with agreed-upon timetables for completing the post-market studies, FDA said.
How Architects Shape the Future of Healthcare Facilities
UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital
Sarasota Memorial Hospital Plans to Build New Facility in North Port
CMMS, Data and the Path to Compliance
Healthcare is a Major Ransomware Target